Investigational Antiviral Therapy Reduces Long-COVID-Related Fatigue and Sleep Disturbance

A twice-daily, low-dose regimen demonstrated a clinically meaningful reduction in long-COVID-related fatigue and sleep disturbances compared to placebo.